BAYVIEW LEGACY sells 50,000 AIP shares under 10b5-1
BAYVIEW LEGACY, LLC reported multiple 10b5-1 sales of Common stock.
Rhea-AI Filing Summary
BAYVIEW LEGACY, LLC reported multiple 10b5-1 sales of Common stock. The transactions occurred between 01/08/2026 and 03/26/2026, with individual trades including 50,000 shares on 01/08/2026 for $829,155.00 and 41,000 shares on 03/09/2026 for $582,626.40. The filing also lists 11,800 Restricted Stock Units dated 04/01/2026.
Positive
- None.
Negative
- None.
Insights
Multiple scheduled 10b5-1 dispositions by an affiliated entity, with several large sales.
The excerpt lists sequential 10b5-1 sales by BAYVIEW LEGACY, LLC between 01/08/2026 and 03/26/2026, showing trade sizes and proceeds per trade (for example, $829,155.00 for 50,000 shares on 01/08/2026). This pattern is consistent with systematic plan-based dispositions rather than one-off open-market trades.
Cash‑flow treatment to the issuer is not stated in the excerpt; timing and plan mechanics are internal to the selling entity. Subsequent filings could disclose total aggregated proceeds or plan terms.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Common financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BAYVIEW LEGACY disclose in the Form 144 filing for AIP?
Does the Form 144 show any newly issued securities for AIP?
Were the sales reported as part of a 10b5-1 plan in the AIP filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.